Arrhythmia/EP
Sep 28, 2009 14:20 EDT
The results of MADIT-CRT suggest patients with early stage (NYHA class I/II) symptomatic heart failure (HF) indicated for an implantable cardioverter defibrillator (ICD) may benefit from the addition of cardiac resynchronization therapy (CRT). How likely are these results to increase device implant rates? Take our poll and see how your colleagues responded.
Acknowledgements
CME provider: Medscape, LLC.
The Arrhythmia Management and Electrophysiology clinical theme is supported by an independent educational grant from Medtronic.
button
Steering committee
The steering committee members are active in overseeing the development and direction of this educational series.

Gregg C. Fonarow, MD
David L. Hayes, MD
Robert C. Kowal, MD
Francis E. Marchlinski, MD
Eric N. Prystowsky, MD
Previews
Featured CME
Resource center
Poll
Health risks of extended work hours warrant changing the way physicians’ shifts are scheduled in hospitals.
See: Another in-hospital CV risk marker: 24-hour shifts with overnight on-call duty
True
False